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Hypertension is related to kidney failure in several ways. It is both a cause and a consequence of kidney disease.[@ref1] The relationship between high blood pressure (BP) and the kidneys could be related to that between "the chicken and the egg."[@ref2] Hypertension is among the leading causes of end-stage renal disease (ESRD) in Nigeria.[@ref3][@ref4] Hypertension also commonly complicates chronic kidney disease (CKD). It may be present in up to 80%--85% of patients with CKD.[@ref5] Hypertension is more common among the patients who are just initiating dialysis because almost all such patients are volume overloaded.[@ref6] Hypotension, on the other hand, frequently leads to decreased renal perfusion and may result in acute kidney injury (AKI).

Hemodialysis (HD) is the most common form of renal replacement therapy (RRT) in Nigeria today.[@ref7] Due to hemodynamic changes, the HD procedure itself is associated with fluctuations in BP which may manifest as hypotension or hypertension. Intradialytic hypotension (IDH) is often defined as a decrease in systolic BP (SBP) by \>20 mmHg or a decrease in the mean arterial blood pressure (MABP) by 10 mmHg, associated with symptoms that may include abdominal discomfort, yawning, sighing, nausea, vomiting, muscle cramps, restlessness, dizziness, fainting, and anxiety.[@ref8] The European Best Practice Guidelines definition is slightly modified to include the presence of symptoms and need for nurses\' intervention.[@ref9] The prevalence of IDH in some parts of Nigeria has been reported to be about 8.5% though this depends on the criteria used for the diagnosis.[@ref10][@ref11]

Although intradialysis BP rise is also a recognized complication in these patients, there is as yet no universally accepted definition. Intradialytic hypertension (IDHTN) has been reported as a rise in the mean arterial pressure \>15 mmHg within or immediately postdialysis or as a \>10 mmHg increase in SBP, or in some cases, BP rise of any degree during the second or third intradialytic hour.[@ref12][@ref13][@ref14] The underlying mechanism of IDHTN is multifactorial and may include activation of renin--angiotensin--aldosterone system and endothelial dysfunction.[@ref15] IDHTN has been reported in about 13.2% of patients on maintenance HD.[@ref13]

Controversies exist concerning acceptable BP levels in ESRD patients. However, higher cardiovascular mortality rates have been observed in patients with postdialytic SBP \>140 mmHg and those with posttreatment SBP \< 110 mmHg in some series.[@ref14] Reports have linked IDHTN to poor clinical outcomes with higher rates of hospitalization and death.[@ref13][@ref16] IDH, on the other hand, impacts negatively on patients\' quality of life and can induce cardiovascular events including cardiac arrhythmia, coronary, or cerebral ischemic disease.[@ref17][@ref18]

Against this background, the objective of the study was to examine BP variability during dialysis, to determine the frequency of IDH and IDHTN in the patients undergoing HD, and to possibly identify associated factors. There is a paucity of data on this subject in this part of the world. The information derived from the study will not only help in cultivating a high index of suspicion and quick identification of these conditions in this vulnerable population but also place the physician on alert for prompt intervention and management.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

This study was a retrospective one involving patients admitted to the HD unit over a 4-year period from June 2014 to June 2018 in the Rainbow Dialysis Center, a private dialysis center in Yenagoa, Nigeria. The Center serves as a referral center for several hospitals in Bayelsa State and neighboring states.

The case files of the patients dialyzed in the unit during this period were retrieved. The second session of HD was used for the study. Data from the first session were not used because they lasted for only 2 h according to the hospital dialysis protocol. Patients who failed to complete the expected 4 h of dialysis during the second session were also excluded from the study. Patients were dialyzed with bicarbonate dialysis, with a hollow-fiber F6 or F8 NIPRO dialyzer. Blood flow rates ranged between 150 and 350 ml/min. The dialysate flow rate ranged between 500 and 650 ml/min. The ultrafiltration goal varied and was determined after the physician had subjectively assessed the quantity of fluid retained in the patient. The dialysate temperature ranged from 36.5°C to 36.9°C. Anticoagulation was with heparin given at a dose of 2000 IU at the start of the dialysis and 1000 IU/h subsequently.

Variables obtained from the case files were age; gender; type of kidney disease; cause of kidney disease; SBP at the onset of the dialysis, middle, and at the end of the dialysis; and diastolic BP (DBP) at the onset, middle of, and at the end of the dialysis. The BP recording on each occasion was the arithmetic mean of two values done at an interval of 3 min. Laboratory data obtained were the hematocrit, serum urea, and serum creatinine.

BP variation during the dialysis was determined by finding the difference between pre-HD and post-HD BPs. Pulse pressure (PP) pre- and post-HD was calculated as the difference between pre-HD SBP and pre-HD DBP as well as between post-HD SBP and post-HD DBP, respectively. MABP pre- and post-dialysis was calculated as follows: MABP = 1/3 (PP) + DBP for their respective pressures.

IDH was defined as a negative difference \>10 mmHg between the pre-HD MABP and the post-HD MABP.[@ref9] IDHTN, on the other hand, was defined as a positive difference of ≥15 mmHg between the pre-HD SBP and the post-HD SBP.[@ref14] Patients with negative or positive differences less than these values were considered as not having significant changes in BP intradialysis.

Data obtained were analyzed using IBM SPSS software version 20.0 (IBM Inc., Chicago, USA). Data were presented as tables. Continuous variables were expressed as mean, standard deviation, and range, while categorical variables were expressed as frequencies and percentages. Means were compared using Student\'s *t*-test or analysis of variance where appropriate. Chi-square test was used to compare proportions. *P* \< 0.05 was considered statistically significant.
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Ethical approval for the study was obtained from the Bayelsa State Ministry of Health.
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=====================

One hundred and forty-nine patients were dialyzed over the study period, of which 136 (91.3%) cases met the inclusion criteria and were recruited for the study. There were 66 males and 70 females. The mean age of patients was 48.1 ± 17.1 years. Only a quarter of the population was above 60 years old. Up to 73.5% of patients were of Bayelsa State origin, while others were from neighboring states of Nigeria. The baseline characteristics of the patients are shown in [Table 1](#T1){ref-type="table"}.

###### 

Baseline parameters of the study population (*n*=136)

  Parameter                          Frequency (%)
  ---------------------------------- ---------------
  Mean age (years)                   48.1±17.1
  Age groups                         
   ≤40                               48 (35.3)
   41-60                             54 (39.7)
   \>60                              34 (25.0)
  Gender                             
   Male                              66 (48.5)
   Female                            70 (51.5)
  Type of kidney disease (*n*=136)   
   AKI                               24 (17.6)
   CKD                               107 (78.7)
   Not specified                     5 (3.7)
  Etiology of CKD (*n*=107)          
   Hypertension                      42 (39.3)
   Chronic glomerulonephritis        25 (23.4)
   HIV associated                    15 (14.0)
   Diabetes mellitus                 12 (11.2)
   Obstructive nephropathy           8 (7.5)
   Others                            5 (4.6)

CKD -- Chronic kidney disease; AKI -- Acute kidney injury; HIV -- Human immunodeficiency virus

The mean predialysis SBP for males and females was 146.9 mmHg and 147.9 mmHg, respectively, while the mean predialysis DBP for males and females was 87.1 mmHg and 88.4 mmHg, respectively. Furthermore, the mean MABP was 107.7 mmHg, while the mean MABP postdialysis was 109.4 mmHg. There was no statistically significant difference in the MABP variation between males and females (*P* = 0.462), as shown in [Table 2](#T2){ref-type="table"}. Patients with CKD also had higher mean predialysis SBP, DBP, and MABP compared with those with AKI. Similarly, the mean postdialysis SBP, PP, and MABP were also higher among the CKD groups \[[Table 2](#T2){ref-type="table"}\].

###### 

Pre- and post-dialysis blood pressure parameters across gender and kidney disease type

  Parameters      Variables                                                                                         
  --------------- -------------- -------------- -------------- ------- -------------- -------------- -------------- ---------
  Pre-dialysis                                                                                                      
   SBP            147.39±31.68   146.89±31.89   147.86±31.71   0.860   131.67±26.65   152.01±31.76   124.00±18.17   0.004\*
   DBP            87.79±19.27    87.12±17.95    88.43±20.55    0.693   80.42±18.53    90.37±18.80    68.00±14.83    0.004\*
   PP             59.60±23.99    59.77±25.88    59.43±22.26    0.934   51.25±21.12    61.64±24.41    59.60±24.00    0.151
   MABP           107.66±21.31   107.05±20.13   108.24±22.51   0.745   97.50±19.14    107.92±20.95   86.67±11.79    0.001\*
  Post-dialysis                                                                                                     
   SBP            151.67±33.90   150.30±34.55   152.96±33.47   0.650   135.00±32.84   156.45±33.29   129.40±17.94   0.006
   DBP            88.30±20.06    88.03±21.43    88.56±18.83    0.879   82.50±19.62    90.09±20.16    77.80±12.81    0.120
   PP             63.37±23.70    62.27±24.92    64.40±22.63    0.604   63.50±23.70    66.36±23.08    51.60±16.21    0.017
   MABP           109.42±22.94   108.79±23.79   110.02±22.27   0.581   100.02±21.96   112.21±22.85   95.00±12.58    0.021

\*Statistically significant. BP -- Blood pressure; SBP -- Systolic BP; DBP -- Diastolic BP; PP -- Pulse pressure; MABP -- Mean arterial BP; AKI -- Acute kidney injury; CKD -- Chronic kidney disease

The postdialysis SBP, DBP, PP, and MABP were generally higher than the predialysis values \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparison of pre- and post-dialysis blood pressure parameters

  Parameter   Predialysis    Postdialysis   *P*
  ----------- -------------- -------------- ---------
  SBP         147.39±31.7    151.67±33.90   \<0.001
  DBP         87.79±19.3     88.30±20.06    \<0.001
  PP          59.60±23.99    63.37±23.71    \<0.001
  MABP        107.66±21.31   109.42±22.94   \<0.001

BP -- Blood pressure; SBP -- Systolic BP; DBP -- Diastolic BP; PP -- Pulse pressure; MABP -- Mean arterial BP

IDH was observed in 23 (16.9%) patients, while IDHTN was found in 22 (16.2%) patients. Similarly, there was no significant intra-dialysis BP variation in 81 (66.9%) patients.

Factors associated with IDH and IDHTN in the patients are shown in the regression analysis in [Table 4](#T4){ref-type="table"}. Age was positively associated with IDH. The older individuals were slightly more likely to develop IDH (odds ratio 1.04, 95% confidence interval = 1.00--1.09). IDH had no relationship with gender, nature of kidney disease, the level of predialysis SBP or DBP, and hematocrit, urea, or creatinine level. None of these variables also had any significant association with IDHTN.

###### 

Regression analysis of factors associated with IDH and IDHTN

  Variable                 *P*       
  ------------------------ --------- -------
  Age                      0.047\*   0.911
  Gender                   0.258     0.686
  Predialysis SBP          0.999     0.989
  Predialysis DBP          0.080     0.985
  Type of kidney disease   0.275     0.954
  Haematocrit              0.308     0.308
  Serum urea               0.324     0.608
  Serum creatinine         0.501     0.246

\*Statistical significance. BP -- Blood pressure; SBP -- Systolic BP; DPB -- Diastolic BP; IDH -- Intradialysis hypotension; IDHTN -- Intradialysis hypertension

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

This finding of this study is in keeping with the current realities in Nigeria and sub-Saharan Africa where CKD affects predominantly the young- and middle-aged individuals with this age bracket also constituting the bulk of the dialysis population.[@ref17] The male-to-female ratio in this small center study was almost unity though the prevalence of RRT has generally been reported to be higher among men.[@ref19]

CKD patients made a large bulk of the study population. Although AKI may also progress directly to ESRD, especially if left untreated, the usual course of CKD is relentless progress to ESRD over time. A major challenge of CKD patients in developing countries like ours is a late presentation, with most patients doing so in an advanced stage.[@ref20]

Hypertension was prevalent in this population. The mean BP s pre- and postdialysis were high. There was no significant difference in BP between males and females even though the latter had slightly higher BPs. In a similar study in Benin City, a nearby town, Okaka and Okwuonu reported higher mean BPs among women compared with males in their series of dialysis patients with only the difference in DBP reaching statistical significance.[@ref21]

BP variability was common in our study as observed in up to one-third of our patients. IDH was reported to be present in up to 17.2% of all treatments in a large dialysis population study involving 1137 patients and over 44,800 treatments.[@ref22] We found a similar rate in this study. However, adequate comparison between studies is constrained by the lack of uniformity and the use of different criteria. Some of these require only a minimum drop in BP, while others include clinical manifestations. In this study, we used a drop in MABP in the absence of clinical manifestations. Since the study was a retrospective one, we could only rely on documented data. The findings are slightly less than those of Okaka and Okwuonu who reported a prevalence of 19.8%.[@ref21] However, the criteria for diagnosis in that study differed from the one we employed. Similarly, Okoye *et al*. in Delta State, Nigeria, reported a prevalence of 8.8%.[@ref11] The criteria for diagnosis used in this case incorporated both SBP drop and clinical manifestations. This may explain why they had a markedly lower rate. We did not find any association between IDH and most of the variables tested in this study. Older age was however only weakly associated with it. IDH has been reported to be more common in the elderly, diabetics, and those with cardiovascular compromise and low predialysis SBP due to the contraction in blood volume that could occur in these patients, especially after significant ultrafiltration.[@ref23] IDH was not related to the predialysis BP levels or the level of serum electrolytes. Pakfetrat *et al*. reported no significant correlation between predialysis SBP, DBP, or serum electrolytes apart from serum magnesium level, which decrease was observed to correlate with IDH.[@ref24] However, we did not test for serum magnesium in this study.

Intradialytic hypertension was similarly prevalent in the population studied. There is a paucity of data on the prevalence of IDHTN in Nigeria, thus placing a limit on the adequate comparison. Okaka and Okwuonu reported a higher rate of 30% in their population,[@ref21] but here again, the criterion used was different from ours. While we used a drop in MABP \>10 mmHg for our patients, a SBP drop of \>20 mmHg was used in theirs. Another South African study reported a prevalence of 28%,[@ref25] while Nilrohit *et al*. reported an even higher prevalence of 34.5% in India.[@ref26] IDHTN was defined in the latter study as an increase in SBP \>10 mmHg during HD for more than two HD sessions, while in the former, it was defined as a \>10 mmHg increase in SBP in at least four of six prior consecutive HD sessions. Ours is one of the few studies that have used MABP as criteria for the diagnosis. Furthermore, only a solitary session of dialysis was used in our study. In the study done by Okaka and Okwuonu, the average values of three dialysis sessions were used, giving a prevalence of 30%.[@ref21] Factors that have been reported to contribute to IDHTN in our environment include fluid overload, infrequent dialysis, inadequate antihypertensive therapy due to financial constraints and poor funding as well as the use of dialyzable antihypertensives during the procedure.^21^

This study had some limitations. Certain variables which have shown some association with IDH/IDHTN in previous reports such as serum albumin, diabetes, presence of edema, use of antihypertensive medications, and erythropoietin were not tested in our study.[@ref26] The effect of HD treatment-related variables such as ultrafiltration rate, dry weight, blood, or dialysate flow was not assessed. The study is underpowered to significantly demonstrate association between variables, considering the relative small number of patients. Furthermore, being retrospective in nature, it does not establish causation for any of the risk factors of IDH or IDHTN. There is a need for large-scale prospective studies to evaluate risk factors for IDH and DHTN to ultimately reduce cardiovascular complications of ESRD.

C[ONCLUSIONS]{.smallcaps} {#sec1-5}
=========================

HD-related hemodynamic instability is a major issue. IDH and IDHTN were prevalent in both AKI and CKD patients undergoing HD in this study. IDH was weakly associated with older age. There is, therefore, a need for greater caution during HD, especially for older patients to prevent the associated risks of the procedure. Thorough preassessment and monitoring of all the patients undergoing HD is necessary for the effective prevention and treatment of IDH and IDHTN to reduce dialysis-related morbidity and mortality while ensuring optimal treatment.

Financial support and sponsorship {#sec2-2}
---------------------------------

Nil.

Conflicts of interest {#sec2-3}
---------------------

There are no conflicts of interest.
